Cleared Traditional

K933929 - LAB-SITE(R) SAFETY CANNULA

K933929 is an FDA 510(k) clearance for LAB-SITE SAFETY CANNULA, manufactured by Migada, Ltd.. The device is a Class 2 Anesthesiology device with product code CBF cleared through the Traditional 510(k) pathway after a 119-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1993
Decision
119d
Days
Class 2
Risk

K933929 is an FDA 510(k) clearance for the LAB-SITE(R) SAFETY CANNULA. Classified as Chamber, Hyperbaric (product code CBF), Class II - Special Controls.

Submitted by Migada, Ltd. (Israel, IL). The FDA issued a Cleared decision on December 7, 1993 after a review of 119 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5470 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Migada, Ltd. devices

FDA 510(k) Submission Details - K933929

510(k) Number K933929 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 10, 1993
Decision Date December 07, 1993
Days to Decision 119 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 140d · This submission: 119d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CBF Device Classification - Class 2, Special Controls

Product Code CBF Chamber, Hyperbaric
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5470
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CBF Chamber, Hyperbaric

All 33
Devices cleared under the same product code (CBF) and FDA review panel - the closest regulatory comparables to K933929.
SYSTEM ONE HYPERBARIC CHAMBER
K951044 · Nth Systems, Inc. · Jan 1996
MODEL 2500E/2500ER HYPERBARIC CHAMBER
K934164 · Sechrist Industries, Inc. · Jun 1995
MODEL 3200P/3200PR HYPERBARIC CHAMBER
K950386 · Sechrist Industries, Inc. · Jun 1995
HYPERBARIC PENETRATION EXTENSION SET
K861315 · Cutter Laboratories, Inc. · May 1986
MICROSPAN -PH MONITOR
K842303 · Biochem International, Inc. · Oct 1984